Progyny, Inc. (PGNY)
Market Cap | 3.02B |
Revenue (ttm) | 786.91M |
Net Income (ttm) | 30.36M |
Shares Out | 93.38M |
EPS (ttm) | 0.30 |
PE Ratio | 108.17 |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 631,456 |
Open | 31.71 |
Previous Close | 31.29 |
Day's Range | 31.12 - 32.69 |
52-Week Range | 25.67 - 53.10 |
Beta | 1.55 |
Analysts | Buy |
Price Target | 45.08 (+39.48%) |
Earnings Date | May 3, 2023 |
About PGNY
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimburseme... [Read more]
Financial Performance
In 2022, Progyny's revenue was $786.91 million, an increase of 57.19% compared to the previous year's $500.62 million. Earnings were $30.36 million, a decrease of -53.84%.
Financial StatementsAnalyst Forecast
According to 12 analysts, the average rating for PGNY stock is "Buy." The 12-month stock price forecast is $45.08, which is an increase of 39.48% from the latest price.
News

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation - PGNY
NEW YORK , March 31, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Progyny, Inc. (NASDA...

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation - PGNY
NEW YORK , March 31, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Progyny, Inc. (NASDA...

Children's Hospital Association Selects Progyny as Exclusive Partner for Fertility and Family Building Benefits
As the vendor of choice, Progyny's comprehensive benefit with proven clinical outcomes will be recommended to the more than 220 children's hospitals in the CHA network As the vendor of choice, Progyny...

Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum
NEW YORK, March 20, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that ...

Progyny Enhances Male Fertility Offering with the Expansion of its Reproductive Urologist Network
NEW YORK, March 14, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) a leading benefits management company specializing in fertility and family building benefits solutions, today announced the ex...

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation - PGNY
NEW YORK , March 3, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Progyny, Inc. (NASDAQ...

A Barron's Portfolio of Stocks Outperformed This Week. Alcoa, Progyny and Other Stocks That Popped.
The Barron's portfolio dropped 1.2% in the past five days, compared with a 1.77% dip in the S&P 500 stock index.

NATIONALLY RANKED ROSEN LAW FIRM Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation – PGNY
NEW YORK--(BUSINESS WIRE)---- $PGNY #PGNY--WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Progyny, Inc. (NASD...

Progyny (PGNY) Q4 Earnings and Revenues Beat Estimates
Progyny (PGNY) delivered earnings and revenue surprises of 50% and 1.47%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Progyny, Inc. Announces Fourth Quarter 2022 Results
Reports Full Year Revenue of $786.9 Million, Reflecting 57% GrowthReports Record Quarterly Revenue and Operating Cash Flow of $214.3 Million and $51.5 Million, RespectivelyIssues Financial Guidance fo...

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation - PGNY
NEW YORK , Feb. 24, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Progyny, Inc. (NASDAQ...

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation - PGNY
NEW YORK , Feb. 17, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Progyny, Inc. (NASDAQ...

ROSEN, A Leading Law Firm, Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation - PGNY
New York, New York--(Newsfile Corp. - February 16, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Pro...

Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2022 Results Report
NEW YORK, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its financ...

SHAREHOLDER ALERT: Investigation of Progyny, Inc. (PGNY) Announced by Nationally Ranked Investors' Rights Firm Holzer & Holzer, LLC
Atlanta, Georgia--(Newsfile Corp. - February 7, 2023) - Holzer & Holzer, LLC is investigating whether Progyny, Inc. ("Progyny" or the "Company") (NASDAQ: PGNY) complied with federal securities laws. O...

Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on Progyny, Inc. (Nasdaq: PGNY)
Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on Progyny, Inc. (Nasdaq: PGNY)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY
NEW YORK , Feb. 7, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ: PGNY). Such investors are advised to contact...

Will Progyny (PGNY) Beat Estimates Again in Its Next Earnings Report?
Progyny (PGNY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

In Search of an Earnings Beat? Play These Top 5 Stocks
These top-ranked stocks are likely to beat on bottom line in their next releases. Tap Yum China (YUMC), Impinj (PI), Five Below (FIVE), Hologic (HOLX) and Progyny (PGNY).

7 Stocks With a Forward P/E of 25 to Run Away From
With a rough 2022 spilling into 2023, we're running into a broad list of stocks to avoid. Especially those in the tech space, where high-profile layoffs have picked up amid a severe slowdown in growth...

Progyny to Discuss its Strong 2022 Financial Performance at Upcoming Investor Conference
Anticipates Results to be at the High-End of its Previously Provided Financial GuidanceAnticipates Reporting Record Fourth Quarter Operating Cash Flow of Approximately $50 Million

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Progyny, Inc. - PGNY
New York, New York--(Newsfile Corp. - December 17, 2022) - Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ: PGNY). Such investors are...

ELV vs. PGNY: Which Stock Is the Better Value Option?
ELV vs. PGNY: Which Stock Is the Better Value Option?

Looking for Earnings Beat? Buy These 5 Stocks With Potential
These top-ranked stocks -- Chewy (CHWY), Progyny (PGNY), KnowBe4 (KNBE), Chegg (CHGG) and Fortinet (FTNT) -- are likely to beat on their bottom line in the next releases.

PGNY EQUITY NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation - PGNY
NEW YORK , Dec. 15, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Progyny, Inc. (N...